FR2270849A1 - Hormone-acrylic polymers - for use as hormone implants in man and animals - Google Patents

Hormone-acrylic polymers - for use as hormone implants in man and animals

Info

Publication number
FR2270849A1
FR2270849A1 FR7417102A FR7417102A FR2270849A1 FR 2270849 A1 FR2270849 A1 FR 2270849A1 FR 7417102 A FR7417102 A FR 7417102A FR 7417102 A FR7417102 A FR 7417102A FR 2270849 A1 FR2270849 A1 FR 2270849A1
Authority
FR
France
Prior art keywords
hormone
man
animals
acrylic polymers
implants
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR7417102A
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to FR7417102A priority Critical patent/FR2270849A1/en
Publication of FR2270849A1 publication Critical patent/FR2270849A1/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C07J1/0025—Esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0011—Androstane derivatives substituted in position 17 by a keto group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/004—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa
    • C07J7/0045—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa not substituted in position 16

Abstract

Polymeric compsns. with a partial formula (I): (where R is H or 1-6C alkyl; R1 is H or 1-6C alkyl; R2 is the residue of an oestrogenic, gestagenic, androgenic and/or anabolic hormonal hydroxy cpds. are useful for hormonal implant compsns. for man and animals.
FR7417102A 1974-05-16 1974-05-16 Hormone-acrylic polymers - for use as hormone implants in man and animals Withdrawn FR2270849A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7417102A FR2270849A1 (en) 1974-05-16 1974-05-16 Hormone-acrylic polymers - for use as hormone implants in man and animals

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7417102A FR2270849A1 (en) 1974-05-16 1974-05-16 Hormone-acrylic polymers - for use as hormone implants in man and animals

Publications (1)

Publication Number Publication Date
FR2270849A1 true FR2270849A1 (en) 1975-12-12

Family

ID=9138953

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7417102A Withdrawn FR2270849A1 (en) 1974-05-16 1974-05-16 Hormone-acrylic polymers - for use as hormone implants in man and animals

Country Status (1)

Country Link
FR (1) FR2270849A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2531089A1 (en) * 1982-07-27 1984-02-03 Pharmascience Lab New oestrane derivatives intended for topical pharmacological application, and process for preparing them
US20170029547A1 (en) * 2015-07-29 2017-02-02 Shin-Etsu Chemical Co., Ltd. Resist composition and patterning process using the same

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2531089A1 (en) * 1982-07-27 1984-02-03 Pharmascience Lab New oestrane derivatives intended for topical pharmacological application, and process for preparing them
US20170029547A1 (en) * 2015-07-29 2017-02-02 Shin-Etsu Chemical Co., Ltd. Resist composition and patterning process using the same
US10005868B2 (en) * 2015-07-29 2018-06-26 Shin-Etsu Chemical Co., Ltd. Resist composition and patterning process using the same

Similar Documents

Publication Publication Date Title
ES303092A1 (en) Apparatus for the correction of the problems of the movement of the language. (Machine-translation by Google Translate, not legally binding)
GB1092145A (en) Microbiological conversion of steroids
FR2270849A1 (en) Hormone-acrylic polymers - for use as hormone implants in man and animals
GB950707A (en) Novel steroid compounds, their preparation and formulation into pharmaceutical compositions
GB1274367A (en) 01beta,13beta-DIALKYLGONA-1,3,5(10)-TRIEN-3-OL 3-CYCLOALKYL ETHERS
CA954727A (en) Implant for surgical or dental use
GB1074492A (en) Novel processes for preparing steroid compounds, the comopounds when thus prepared, novel steroid compounds thereby prepared, and pharmaceutical compositions containing the novel compounds
ES363068A1 (en) 11beta-CHLORO-19-NOR-STEROIDS
BE779841R (en) Sulphonyloxy-13-beta-ethyl-gonanes - as oestrogenic-genic anti-fecundity and anti-lipaemic agents
AU293012B2 (en) Process for preparing androst-4-ene-3, 17-dione and androsta-1, 4-diene-3, 17-dione from steroidal compounds bythe action of microorganisms
GB1008273A (en)
AU5550065A (en) Process for preparing androst-4-ene-3, 17-dione and androsta-1, 4-diene-3, 17-dione from steroidal compounds bythe action of microorganisms
CA592342A (en) Hydroxy diketo pregnane anesthetic composition
GB996308A (en) New 19-nor-steroids
ES384155A1 (en) An analogical procedure for the preparation of new steroid compounds. (Machine-translation by Google Translate, not legally binding)
FR2189049A1 (en) 6-Spiro-cyclopropyl-steroids - with aldosterone antagonist activity
JPS57131092A (en) Display correcting device of electronic watch
FR2438055A1 (en) Nor:steroid fertility control agents - of oestrane, androstane and gonane and the corresponding di:homo-steroid(s)
ES266364A2 (en) Injector equipment for the manufacture of dental prostheses elements (Machine-translation by Google Translate, not legally binding)
FR2109621A5 (en) Basic 17-azasteroids - as intermediates from 16- or 20-oxo steroids by reduction with metal hydrides
GB1008272A (en) Process for the manufacture of 19-nor-steroids
AU247654B2 (en) 16 - methyl - 11 - hydroxy - androsta -1,4 - dien - 3, 17 - dione and process for its preparation
ES388852A1 (en) Novel 16-methylene-9{62 , 10{60 -steroid compounds, pharmaceutical preparations which contain the novel compounds as active ingredients, and methods of producing the said compounds and preparations
FR2244529A1 (en) Di-steroid ethers - with improved hormonal activity, especially anabolic and progestational activity
JPS52144166A (en) Filth introducing device for filth reservoir

Legal Events

Date Code Title Description
ST Notification of lapse